GENE ONLINE|News &
Defence Therapeutics to Present Accum Drug-Delivery Platform at World ADC Europe 2026 in February
Defence Therapeutics announced its participation in the World ADC Europe 2026 conference, where it will showcase its Accum Precision Intracellular Drug-Delivery Platform. The event is scheduled to take place from February 4 to February 7, 2026, and will bring together industry leaders and experts in antibody-drug conjugates (ADC) technology. Defence Therapeutics plans to present advancements related to its proprietary platform during the conference.
The Accum platform focuses on enhancing intracellular drug delivery mechanisms, which are critical for improving the efficacy of therapeutic agents. Defence Therapeutics has stated that this technology aims to optimize drug targeting within cells, potentially addressing challenges associated with ADC therapies. The company’s presentation at World ADC Europe 2026 will provide insights into its research and development efforts surrounding this platform.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: February 4, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Amrize Corporation Appoints Three New Directors Following Departure of James Carter and Linda Nguyen
2026-02-11
Study Maps Cellular and Molecular Changes in Pancreatic Tissue During Type 1 Diabetes Progression
2026-02-11
Applied Materials Resolves U.S. Export Control Investigation with Financial Penalty and Compliance Measures
2026-02-11
